13F HOLDINGS REPORT
MWG Management Ltd.
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0000950123-23-010382
Total Value
$103.2M
Positions
3
Other Managers
1
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BEAM THERAPEUTICS INC | BEAM | 2,346,934 | $56.4M | 54.70% |
| 2 | LYELL IMMUNOPHARMA INC | LYEL | 20,162,332 | $29.6M | 28.73% |
| 3 | PRIME MEDICINE INC | PRME | 1,792,210 | $17.1M | 16.57% |